NCT00003282View on ClinicalTrials.gov

EF5 in Treating Patients With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 1998

Primary Completion Date

May 31, 2005

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

EF5

Given IV

PROCEDURE

therapeutic conventional surgery

Undergo resection

PROCEDURE

biopsy

Undergo biopsy

OTHER

pharmacological study

Correlative studies

Trial Locations (1)

19104

Abramson Cancer Center of The University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00003282 - EF5 in Treating Patients With Solid Tumors | Biotech Hunter | Biotech Hunter